Implementing Telehealth in the Headache Clinic with Jaclyn Duvall, MD
AHS Member Jaclyn Duvall, MD, explains how to implement telemedicine in your headache clinic When the COVID-19 pandemic started, Jaclyn Duvall, MD, a headache specialist in Tulsa, OK, knew that her clinic would need to make immediate changes to reduce the risk of viral transmission while providing headache care for patients. During her Facebook Live for the American Headache Society, Dr. Duvall explained how to use telemedicine in the headache clinic and provides resources that may help providers transition to telemedicine. Tips for Implementing Telemedicine in the Headache Clinic Choose a Virtual Platform Some HIPPA compliant examples include: Doximity,...Read More
Brad Klein: Member Spotlight
Honoree Brad Klein, MD, MBA, FAHS, talks about the importance of advocacy and business acumen in headache medicine During his headache residency at Thomas Jefferson University in Philadelphia, Brad Klein, MD, MBA, FAHS, saw many people debilitated by their headache disorder. Some were “unable to maintain a marriage or a family, let alone a career, often with depression, anxiety, and sleep deprivation, amongst other ailments,” he says. After empowering them to better understand their disorder, providing direction on how to care for themselves better and then offering treatments to control their pain, Dr. Klein saw many patients turn their lives...Read More
Telemedicine in the Age of the COVID-19 Pandemic
New insights about virtual care are especially relevant as hospitals face COVID-19 pandemic An article recently published in Cephalalgia examines whether synchronous video-based telemedicine visits with specialists are feasible, and evaluates clinical effectiveness, patient perceptions, and other benefits of telemedicine visits for follow-up migraine care in a tertiary headache center. “Telemedicine visits are beneficial to both patients and providers as they take less time to complete and provide more convenience to patients,” says Jessica Kiarashi, MD, a neurologist at The University of Texas Southwestern Medical Center, who spoke to AHS about the study. These types of consultations, she says, achieve...Read More
Headache Clinic Workflows During the COVID-19 Pandemic
Telemedicine and precaution can provide relief safely, according to Nina Riggins, MD, Ph.D, and Rashmi Halker Singh, MD, FAHS, FAAN The COVID-19 pandemic has fundamentally altered how clinicians are able to see and treat their patients, and headache specialists are no different. Faced with an unprecedented situation, physicians are turning to each other to determine the best practices for COVID-19 workflows to help their patients while also protecting themselves. Rashmi Halker Singh, MD, FAHS, FAAN, a headache medicine neurologist at Mayo Clinic, has found insight from neurology groups that she belongs to on social media. “People are saying ‘This is...Read More
Providers Stand with Patients at Headache on the Hill
American Headache Society members go to Capitol Hill to advocate with and for their patients This past February, AHS members turned out in large numbers to represent the headache medicine community at the 13th Annual Headache on the Hill. At this legislative advocacy event, patients and providers work in tandem to lobby and educate their representatives and lawmakers about migraine and other headache disorders. This year, participants asked their representatives to amend and pass the Opioid Workforce Act H.R.3414 / S.2892, a bill that could greatly increase the number of doctors trained to treat migraine and headache disorders. ...Read More
Lauren Doyle Strauss: Member Spotlight
Our March Member Spotlight, Lauren Doyle Strauss, DO, FAHS, dedicates her career to advancing headache treatment through education This month, the American Headache Society is proud to spotlight Lauren Doyle Strauss, DO, FAHS. Dr. Strauss’s work as a pediatric neurologist centers on improving the lives of children with headache disorders through educating patients, parents and other healthcare professionals. She is involved in the New Investigators and Trainees, Pediatric-Adolescent Headache and Refractory, Inpatient and Emergency Care Special Interest Sections and the Electronic Media Committee. Dr. Strauss’s undergraduate degree was in bioengineering with a focus on physics and math. “I thought when...Read More
Breaking News: Eptinezumab-jjmr (VYEPTI™) Approved by FDA
Eptinezumab, the first intravenous treatment for migraine prevention, approved by the FDA On February 21, 2020, the FDA approved eptinezumab-jjmr (VYEPTI™) for the preventive treatment of migraine in adults. This is the first intravenous (IV) treatment for migraine prevention and the latest in a new class of monoclonal antibodies used for the preventive treatment of migraine. The treatment was evaluated through two phase III clinical trials (PROMISE-1 in episodic migraine and PROMISE-2 in chronic migraine), which demonstrated the efficacy and safety of eptinezumab. The primary endpoint was the change from baseline in mean MMD over months 1-3. Clinical Trials In...Read More
The Future of Neuromodulation: Q&A
Michael L. Oshinsky, PhD, discusses how headache researchers can shape the future of neuromodulation Michael L. Oshinsky, PhD, is the program director of Pain and Migraine at the National Institute of Neurological Disorders and Stroke within the National Institutes of Health. He is also a chair of the basic and translational pain research portion of the NIH HEAL (Helping to End Addiction Long-term) Initiative, for which Congress gave the NIH $500 million to address opioid use disorder and to enhance pain management with non-opioid options to treat pain and headache. Dr. Oshinsky spoke with us about the future of neuromodulation...Read More
Mia Minen: Member Spotlight
This month’s spotlight honoree discusses migraine as a public health crisis and frontline disorder Our February member spotlight is Mia Minen, MD, MPH, FAHS, an AHS member whose work focuses on improving the diagnosis and treatment of people with migraine by doctors in various medical specialties, including emergency medicine, primary care, psychiatry and other specialty areas. She’s also the chair of all AHS Special Interest Sections: “I’m like the Chair of Chairs,” she jokes. She has been committed to pursuing research to improve migraine care across disciplines, and has secured grants from the NIH, the American Academy of Neurology-American Brain...Read More